BDBM697212 1-[[2- (difluoromethoxy) pyridin-4- yl]methyl]-3- [(8R)-5- oxaspiro[3.5] nonan-8-yl]urea::US20240316020, Example 27
SMILES FC(F)Oc1cc(CNC(=O)N[C@@H]2CCOC3(CCC3)C2)ccn1
InChI Key InChIKey=XSTKLKXCRKKDOX-UHFFFAOYSA-N
Data 3 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 3 hits for monomerid = 697212
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
ICAGEN, LLC; HOFFMANN-LA ROCHE INC.
US Patent
ICAGEN, LLC; HOFFMANN-LA ROCHE INC.
US Patent
Affinity DataEC50: 260nMAssay Description:Human Kv7.2, Kv7.4 or Kv7.5/7.3 channels were evaluated using a voltage protocol in which cells were voltage-clamped at a holding potential of -60 mV...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
ICAGEN, LLC; HOFFMANN-LA ROCHE INC.
US Patent
ICAGEN, LLC; HOFFMANN-LA ROCHE INC.
US Patent
Affinity DataEC50: 260nMAssay Description:Human Kv7.2, Kv7.4 or Kv7.5/7.3 channels were evaluated using a voltage protocol in which cells were voltage-clamped at a holding potential of -60 mV...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 3/5(Human)
ICAGEN, LLC; HOFFMANN-LA ROCHE INC.
US Patent
ICAGEN, LLC; HOFFMANN-LA ROCHE INC.
US Patent
Affinity DataEC50: >3.00E+4nMAssay Description:Human Kv7.2, Kv7.4 or Kv7.5/7.3 channels were evaluated using a voltage protocol in which cells were voltage-clamped at a holding potential of -60 mV...More data for this Ligand-Target Pair